Terms: = Colorectal cancer AND RALGDS, FLJ20922, 5900, ENSG00000160271, RalGEF, RGF, Q12967
16 results:
1. Modulation of autophagy: a Phase II study of vorinostat plus hydroxychloroquine versus regorafenib in chemotherapy-refractory metastatic colorectal cancer (mCRC).
Arora SP; Tenner L; Sarantopoulos J; Morris J; Liu Q; Mendez JA; Curiel T; Michalek J; Mahalingam D
Br J Cancer; 2022 Oct; 127(6):1153-1161. PubMed ID: 35739299
[TBL] [Abstract] [Full Text] [Related]
2. BMP4 and PHLDA1 are plausible drug-targetable candidate genes for KRAS G12A-, G12D-, and G12V-driven colorectal cancer.
Ohnami S; Maruyama K; Chen K; Takahashi Y; Hatakeyama K; Ohshima K; Shimoda Y; Sakai A; Kamada F; Nakatani S; Naruoka A; Ohnami S; Kusuhara M; Akiyama Y; Kagawa H; Shiomi A; Nagashima T; Urakami K; Yamaguchi K
Mol Cell Biochem; 2021 Sep; 476(9):3469-3482. PubMed ID: 33982211
[TBL] [Abstract] [Full Text] [Related]
3. Hospital volume and mortality in liver resections for colorectal metastasis using population-based administrative data.
Hunger R; Mantke A; Herrmann C; Grimm AL; Ludwig J; Mantke R
J Hepatobiliary Pancreat Sci; 2019 Dec; 26(12):548-556. PubMed ID: 31562836
[TBL] [Abstract] [Full Text] [Related]
4. Targeting RAS signaling pathway as a potential therapeutic target in the treatment of colorectal cancer.
Bahrami A; Hassanian SM; ShahidSales S; Farjami Z; Hasanzadeh M; Anvari K; Aledavood A; Maftouh M; Ferns GA; Khazaei M; Avan A
J Cell Physiol; 2018 Mar; 233(3):2058-2066. PubMed ID: 28262927
[TBL] [Abstract] [Full Text] [Related]
5. EphA2 Expression Is a Key Driver of Migration and Invasion and a Poor Prognostic Marker in colorectal cancer.
Dunne PD; Dasgupta S; Blayney JK; McArt DG; Redmond KL; Weir JA; Bradley CA; Sasazuki T; Shirasawa S; Wang T; Srivastava S; Ong CW; Arthur K; Salto-Tellez M; Wilson RH; Johnston PG; Van Schaeybroeck S
Clin Cancer Res; 2016 Jan; 22(1):230-242. PubMed ID: 26283684
[TBL] [Abstract] [Full Text] [Related]
6. An Integrative Approach for Mapping Differentially Expressed Genes and Network Components Using Novel Parameters to Elucidate Key Regulatory Genes in colorectal cancer.
Sehgal M; Gupta R; Moussa A; Singh TR
PLoS One; 2015; 10(7):e0133901. PubMed ID: 26222778
[TBL] [Abstract] [Full Text] [Related]
7. Use of Valtrac™-secured intracolonic bypass in laparoscopic rectal cancer resection.
Ye F; Chen D; Wang D; Lin J; Zheng S
Medicine (Baltimore); 2014 Dec; 93(29):e224. PubMed ID: 25546660
[TBL] [Abstract] [Full Text] [Related]
8. Factors explaining racial/ethnic disparities in rates of physician recommendation for colorectal cancer screening.
Ahmed NU; Pelletier V; Winter K; Albatineh AN
Am J Public Health; 2013 Jul; 103(7):e91-9. PubMed ID: 23678899
[TBL] [Abstract] [Full Text] [Related]
9. RASSF2 hypermethylation is present and related to shorter survival in squamous cervical cancer.
Guerrero-Setas D; Pérez-Janices N; Blanco-Fernandez L; Ojer A; Cambra K; Berdasco M; Esteller M; Maria-Ruiz S; Torrea N; Guarch R
Mod Pathol; 2013 Aug; 26(8):1111-22. PubMed ID: 23542458
[TBL] [Abstract] [Full Text] [Related]
10. Differential involvement of RalA and RalB in colorectal cancer.
Martin TD; Der CJ
Small GTPases; 2012; 3(2):126-30. PubMed ID: 22790202
[TBL] [Abstract] [Full Text] [Related]
11. Genetic and epigenetic alterations in primary colorectal cancers and related lymph node and liver metastases.
Miranda E; Bianchi P; Destro A; Morenghi E; Malesci A; Santoro A; Laghi L; Roncalli M
Cancer; 2013 Jan; 119(2):266-76. PubMed ID: 22786759
[TBL] [Abstract] [Full Text] [Related]
12. [Methods to increase participation in cancer screening programmes].
Giorgi Rossi P; Camilloni L; Cogo C; Federici A; Ferroni E; Furnari G; Giordano L; Grazzini G; Iossa A; Jimenez B; Palazzi M; Palazzo F; Spadea T; Senore C; Borgia P; Guasticchi G
Epidemiol Prev; 2012 Jan; 36(1 Suppl 1):1-104. PubMed ID: 22418841
[TBL] [Abstract] [Full Text] [Related]
13. Activation and involvement of Ral GTPases in colorectal cancer.
Martin TD; Samuel JC; Routh ED; Der CJ; Yeh JJ
Cancer Res; 2011 Jan; 71(1):206-15. PubMed ID: 21199803
[TBL] [Abstract] [Full Text] [Related]
14. Molecular biology of squamous cell carcinoma of the anus: a comparison of HIV-positive and HIV-negative patients.
Gervaz P; Hahnloser D; Wolff BG; Anderson SA; Cunningham J; Beart RW; Klipfel A; Burgart L; Thibodeau SN
J Gastrointest Surg; 2004 Dec; 8(8):1024-30; discussion 1031. PubMed ID: 15585390
[TBL] [Abstract] [Full Text] [Related]
15. Methylation profile of the promoter CpG islands of 31 genes that may contribute to colorectal carcinogenesis.
Xu XL; Yu J; Zhang HY; Sun MH; Gu J; Du X; Shi DR; Wang P; Yang ZH; Zhu JD
World J Gastroenterol; 2004 Dec; 10(23):3441-54. PubMed ID: 15526363
[TBL] [Abstract] [Full Text] [Related]
16. Pelvic resection of recurrent rectal cancer.
Wanebo HJ; Koness RJ; Vezeridis MP; Cohen SI; Wrobleski DE
Ann Surg; 1994 Oct; 220(4):586-95; discussion 595-7. PubMed ID: 7524455
[TBL] [Abstract] [Full Text] [Related]
